Sacvaly 97/103Mg 60 Film Coated Tablet

Prescription required: Sacvaly 97/103 mg Tablets (60 Tablets) is a prescription-only medication used in the treatment of chronic heart failure.

Drug Overview

Sacvaly 97/103 mg Tablets (60 Tablets) is a high-strength formulation of sacubitril and valsartan designed for long-term management of chronic heart failure. It helps improve cardiac efficiency, reduce symptoms, and lower the risk of hospitalization. Sacvaly 97/103 mg Tablets is typically prescribed for patients who are stabilized on lower doses and require optimized heart failure therapy.

Active Ingredient and Composition

This medication contains a dual combination of:

• Sacubitril 97 mg – a neprilysin inhibitor that enhances beneficial natriuretic peptides
• Valsartan 103 mg – an angiotensin II receptor blocker (ARB) that lowers blood pressure

Drug Class

Sacvaly belongs to the class of angiotensin receptor neprilysin inhibitors (ARNI), widely used in the management of heart failure with reduced ejection fraction.

Uses of Sacvaly 97/103 mg Tablets

Sacvaly 97/103 mg Tablets (60 Tablets) is indicated for:

• Management of chronic heart failure in adults
• Improving heart pumping efficiency and circulation
• Reducing symptoms such as fatigue and shortness of breath
• Lowering the risk of hospitalization due to worsening heart failure

How Sacvaly 97/103 mg Tablets Works

Sacvaly 97/103 mg Tablets works through a complementary dual mechanism. Sacubitril increases levels of natriuretic peptides that help reduce fluid retention and cardiac stress, while valsartan blocks angiotensin II receptors to promote vasodilation and lower blood pressure. Together, these actions improve heart function and reduce workload on the heart.

Dosage and Administration

The dosage of Sacvaly 97/103 mg Tablets should be individualized and prescribed by a healthcare provider.

• Typically taken twice daily
• May be taken with or without food
• Swallow tablets whole with water
• Usually prescribed after dose titration from lower strengths
• Regular follow-up is required for monitoring

Possible Side Effects

Common side effects may include:

• Low blood pressure (hypotension)
• Dizziness or fatigue
• Elevated potassium levels (hyperkalemia)
• Changes in kidney function

Contraindications

• Hypersensitivity to sacubitril or valsartan
• Concomitant use with ACE inhibitors
• History of angioedema related to similar medications

Drug Interactions

Sacvaly 97/103 mg Tablets may interact with:

• ACE inhibitors and other antihypertensive drugs
• Potassium supplements or potassium-sparing diuretics
• Medications affecting renal function

Always inform your healthcare provider about all medications and supplements you are taking.

Warnings and Precautions

• Use cautiously in patients with kidney or liver impairment
• Monitor blood pressure and potassium levels regularly
• Avoid use in patients with severe hypotension
• Continuous medical supervision is required

Use During Pregnancy and Breastfeeding

This medication is not recommended during pregnancy due to potential fetal risk. Consult a healthcare provider before use during breastfeeding.

Use for Children

The safety and effectiveness in pediatric patients have not been fully established. Use should be determined by a specialist.

Drug Alternatives

Alternative treatments for chronic heart failure may include ACE inhibitors, ARBs, beta-blockers, or other ARNI therapies, depending on patient condition and clinical response.

Comparison With Similar Drugs

Compared with ACE inhibitors or ARBs alone, Sacvaly 97/103 mg Tablets provides a dual-action mechanism that enhances clinical outcomes in heart failure. It is typically used at higher doses for patients requiring advanced optimization of therapy.

Safe Usage Tips

• Take the medication exactly as prescribed
• Do not miss doses or stop treatment abruptly
• Monitor blood pressure and kidney function regularly
• Follow a heart-healthy lifestyle and diet
• Report any unusual symptoms to your doctor

Conclusion

Sacvaly 97/103 mg Tablets (60 Tablets) is a potent and effective option for managing chronic heart failure. With its dual mechanism of sacubitril and valsartan, Sacvaly 97/103 mg Tablets supports improved cardiac function, symptom relief, and better long-term outcomes when used under proper medical supervision.